Skip to content

Effect of self-management program on Quality of life and Self efficacy in women with Polycystic ovary syndrome

Effectiveness of Self-management program on Quality of life and Self efficacy in women with Polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230307057652N1
Enrollment
64
Registered
2023-03-24
Start date
2023-04-09
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: The intervention group receives the self-management program based on the 5A model in the virtual network. In the Assess stage, after effective communication, height

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Diagnosis of polycystic ovary syndrome based on the confirmation of a specialist doctor or recorded in the medical record At least one year has passed since the diagnosis of the disease Being literate in reading and writing Having an Android or iOS smart phone Ability to participate in training sessions Women who live with their husbands and are the only wives of their husbands Being Iranian Age (15-49)

Exclusion criteria

Exclusion criteria: Participation in consulting studies Existence of various types of severe mental disorders (psychosis, schizophrenia, etc.) under medical treatment based on medical record information or statements Smoking, drugs and alcohol Existence of stressful events during the last 6 months such as immigration, death of relatives, divorce Treated with assisted reproductive methods Restrictions on physical activity Having diseases that require following a special diet (such as phenylketonuria)

Design outcomes

Primary

MeasureTime frame
Measuring the average quality of life scores in women with polycystic ovary syndrome. Timepoint: At the baseline and completion of the intervention at week 12. Method of measurement: Quality of life questionnaire for women with polycystic ovary syndrome(Cornin and et al.).;Measuring mean self-efficacy scores in women with polycystic ovary syndrome. Timepoint: At the baseline and completion of the intervention at week 12. Method of measurement: General Self-Efficacy Scale(Scherer).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahnaz Mojahed

Yazd University of Medical Sciences

sh_mojahed@yahoo.com+98 35 3824 1754

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026